(Naturalhealth365) Human papillomavirus, the most common sexually transmitted disease, usually resolves on its own. In rare cases, however, HPV leads to cervical cancer. HPV vaccines, such as Gardasil, are touted by many mainstream medical authorities as a way to prevent cervical cancer. But, could the vaccination actually be having the opposite effect?
A new study raising just this possibility was recently published in a well-regarded medical journal. Soon after, it was officially retracted by the journal’s editors – because the author, fearing repercussions from those opposed to any questioning of vaccines, used a pseudonym.
Age-standardized incidence of cervical cancer in Sweden increased by 20 percent during 2014 and 2015
In an article published April 30, 2018 in the Indian Journal of Medical Ethics (IJME), the author (who identified himself as Lars Andersson, of the Department of Physiology and Pharmacology at the prestigious Karolinska Institute in Sweden) pointed out that the Centre for Cervical Cancer Prevention in Sweden had noted in its annual report that there had been a substantial increase in incidence of invasive cervical cancer – especially during 2014 and 2015.
The increase was shown to be most prominent among women aged 20 to 49 years, who were of an age to have received the HPV vaccinations.
HPV vaccines were approved in Sweden in 2006 and 2007. Andersson notes that about 80 percent of the 12-year-old girls in Sweden were vaccinated in 2010, while 59 percent of 13- to 18-year-old girls were vaccinated through a “catch-up” program.
In addition to suggesting that increased HPV vaccination rates were associated with an increase in cervical cancer, Andersson maintained that a U.S. Food and Drug Administration (FDA) analysis of Gardasil in 2006 showed a higher risk of “premalignant cell changes” from the vaccine in certain groups that had been exposed to some HPV strains.
After the article’s publication, however, there followed a somewhat whiplash-inducing chain of events.
Journal editors confirm: Author faced possible repercussions
A week after publication, the IJME editors removed any mention of the Karolinska Institute from Andersson’s article.
In a published comment, the editors stated that they had made the deletion after being informed by the Institute that no one by the name of “Lars Andersson” worked there.
At this point, the author had proceeded to make his real name known to the editors – under the premise of confidentiality.
The editors stated that they had confirmed that the author had the “necessary qualifications, expertise and research experience” required for the article. They also confirmed that the author did, indeed, face a “credible threat of harm.”
In addition, they reconfirmed the article’s conclusion – that there was “a possible association of the HPV vaccine with increased incidence of carcinoma cervix.” They also agreed with the author that more research is needed.
The editors decided to retain the article.
At this point, the entire editorial board – and other interested parties – began to second-guess the decision and questioned the wisdom of allowing the article to stand.
Ultimately, the editors decided against tolerating the authorial deception – although they still assess the article as correct. On May 8, 2018, the IJME retracted the article, while continuing to call for more exploration on the article’s subject.